PATENT CLAIM ANALYSIS

Application Number: 16032219
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2018-11
Patent Classification: ["435", "287100"]

Abstract:
Devices, systems, or methods are disclosed herein for treatment of disease in a vertebrate subject. The device can include a quasi-planar substrate; and one or more laterally-mobile effector molecule types at least partially embedded within the quasi-planar substrate, wherein the one or more laterally-mobile effector molecule types is configured to interact with one or more cell types. The device can further include one or more sensors configured to detect at least one aspect of an interaction between the at least one of the one or more laterally-mobile effector molecule types and the one or more cell types; and a controller in communication with the one or more sensors, wherein the controller is configured to responsively initiate modification of at least one of the one or more laterally-mobile effector molecule types, the quasi-planar substrate, and the one or more cell types.

Claim (Index 147):
The device of  claim 146 , wherein the antigen includes at least one of a tumor-associated antigen, or viral peptide antigen.

Metadata:
- Claim Count in Document: 43.0
- Percentile: 95.0
- Lexical Diversity: 2.69643
- Patent Class: 435.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14291435', '13135130', '13200496', '14981142', '12789575']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.5818203524677595
- 35 USC 102 Novelty (BERT): 0.5298883050669486
- Combined Prediction Score: 0.5766271477276785
- Mean Citation Score: 243.538482
- Max Citation Score: 328.5025
- Similarity Product: 212.9554997119308

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test